European Pharmaceutical Review

FEBRUARY 21, 2023

After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. How do you see the evolution of cannabis-based medicines, particularly when it comes to the ‘specials’ or fully licensed drug routes? He founded Celadon in 2018.

Medicine 132

Medicine Manufacturing Specialization Pharmaceutical 132

Pharma Pathway

SEPTEMBER 20, 2022

Eugia Pharma Specialities Limited is Subsidiary of Aurobindo Pharma Limited, Aurobindo Pharma Ltd’ (APL). Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations. Job Description. Email Id: hariprasad.vadlamuri@aurobindo.com / harikrishna.gottumukkala@eugia.co.in.

Pharma 86

Pharma Pharmaceutical manufacturing Specialization Safety 86

Pharma Marketing Network

OCTOBER 26, 2020

For companies that process “special categorizes of data, through research and clinical trials etc.,” The GDPR requires any company that processes large amounts of special categories of personal data to appoint a data protection officer , either by recruitment of a new employee or via an outsourced data protection officer.

Pharmaceutical 96

Pharmaceutical Pharma Specialization Healthcare 96

European Pharmaceutical Review

DECEMBER 22, 2022

Targeted entry of mRNA into human cells is a challenging process that requires special delivery systems to protect the therapeutic mRNA from degradation…”. The first drug to be approved with an ionised lipid was Onpattro® (patisiran) for the treatment of hereditary transthyretin protein amyloidosis in 2018. Boisguérin P, et a l.

Medicine 116

Medicine Food and Drug Administration Transportation Distribution 116

Referral MD

DECEMBER 9, 2024

Patient Safety Prior authorization protects patients by: Verifying that prescribed medications or treatments are safe. According to a 2018 AMA survey, 26% of healthcare providers reported waiting three days or more for a decision, highlighting the need for improvements in efficiency. Identify more cost-effective alternatives.

Healthcare 52

Healthcare Healthcare Insurance Healthcare Provider 52

Clarivate

MAY 11, 2023

In parallel, the CDE also established a special channel to facilitate these approvals. Despite the availability of multiple DMTs in the Western markets, there was a dearth of DMTs in Mainland China before 2018. 2] Opinion on the list of new drugs marketed overseas urgently needed in China , August 2018. [3]

Marketing 52

Marketing Patients Management Insurance 52

Clarivate

MAY 24, 2022

6] [7] However, in May 2018, the National Health Commission of China (NHC), together with four other national agencies, formulated China’s First List of Rare Diseases (CRDL) to provide a foundation for policymaking around rare disease treatments. 2018; 40:432-434. (in Source: Clarivate analysis. 10] [11] [12]. 10] [11] [12].

Patients 52

Patients Food and Drug Administration Marketing Pharma 52